Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Cytek Biosciences, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cytek Biosciences Reports Second Quarter 2023 Financial Results"
05/09/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cytek Biosciences Reports First Quarter 2023 Financial Results"
02/28/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results"
02/28/2023 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/13/2023 8-K Quarterly results
11/09/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cytek Biosciences Reports Third Quarter 2022 Financial Results"
08/10/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/02/2022 8-K Quarterly results
02/23/2022 8-K Quarterly results
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/08/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cytek Biosciences Reports Third Quarter 2021 Financial Results"
09/03/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 2, 2021 Cytek Biosciences, Inc. Delaware 001-40632 47-2547526 46107 Landing Pkwy Fremont, California 94538 Registrant's telephone number, including area code: 922-9835 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement co...",
"Cytek Biosciences Reports Second Quarter 2021 Financial Results"
08/30/2021 8-K Quarterly results
07/27/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy